Myasthenia gravis: clinical, immunological, and therapeutic advances (Q36006116)

11 August 2017

1 reference

title

Myasthenia gravis: clinical, immunological, and therapeutic advances (English)

1 reference

11 August 2017

0 references

3

Aarli JA

1 reference

11 August 2017

2

Gilhus NE

1 reference

11 August 2017

Romi F

1

1 reference

PubMed ID

15644074

11 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Acta Neurologica Scandinavica

11 August 2017

1 reference

11 August 2017

111

1 reference

11 August 2017

2

1 reference

11 August 2017

134-141

1 reference

How to handle myasthenic crisis. Essential steps in patient care

11 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Therapy of myasthenic crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Muscle autoantibodies in subgroups of myasthenia gravis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Three Forms of Immune Myasthenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Myasthenia Gravis in Individuals over 40

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Thymomas express epitopes shared by the ryanodine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Thymoma in patients with MG: characteristics and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Inflammation at the neuromuscular junction in myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Inflammatory myopathy in myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Thymectomy and Antimuscle Antibodies in Nonthymomatous Myasthenia Gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

The role of T-cells in the initiation of autoantibody responses in thymoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Pathogenesis of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Molecular mimicry and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Evidence for antigenic cross-reactivity between herpesvirus and the acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Myasthenia gravis: diagnostic and management dilemmas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Thymic lesions and myasthenia gravis. Diagnosis based on mediastinal imaging and pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Treatment of autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Clinical study of fk506 in patients with myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

Therapeutic options in ocular myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00374.X

10.1111/J.1600-0404.2005.00374.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15644074